Masaru Koizumi

Dr. Masaru Koizumi

Department of Surgery, Tochigi Medical Center Shimotsuga
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2014 in Hernia
Verified
Journal Article
Closed access
PDF file
MKMasaru Koizumi
Masaru Koizumi
NSN. Sata
N. Sata
YKY. Kaneda
Y. Kaneda
KEK. Endo
K. Endo
HSHideki Sasanuma
Hideki Sasanuma
YYY. Yasuda
Y. Yasuda

8 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JWJun Watanabe
Jun Watanabe
AMATSUSHI Miki
ATSUSHI Miki
MKMasaru Koizumi
Masaru Koizumi
Kazuhiko KotaniKazuhiko Kotani
Kazuhiko Kotani
NSNaohiro Sata
Naohiro Sata
Background: Previous systematic reviews have not clarified the effect of postoperative coffee consumption on the incidence of postoperative ileus (POI) and the length of hospital stay (LOS). We aimed to assess its effect on these postoperative outcomes. Methods: Studies evaluating postoperative coffee consumption were searched using electronic databases until September 2021 to perform random-effect meta-analysis. The quality of evidence was assessed using the Cochrane risk-of-bias tool. Caffeinated and decaffeinated coffee were also compared. Results: Thirteen trials (1246 patients) and nine ongoing trials were included. Of the 13 trials, 6 were on colorectal surgery, 5 on caesarean section, and 2 on gynecological surgery. Coffee reduced the time to first defecation (mean difference (MD) −10.1 min; 95% confidence interval (CI) = −14.5 to −5.6), POI (risk ratio 0.42; 95% CI = 0.26 to 0.69); and LOS (MD −1.5; 95% CI = −2.7 to −0.3). This trend was similar in colorectal and gynecological surgeries. Coffee had no adverse effects. There was no difference in POI or LOS between caffeinated and decaffeinated coffee (p > 0.05). The certainty of evidence was low to moderate. Conclusion: This review showed that postoperative coffee consumption, regardless of caffeine content, likely reduces POI and LOS after colorectal and gynecological surgery.

19 October 2005 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
MKMasaru Koizumi
Masaru Koizumi
NSNaohiro Sata
Naohiro Sata
KYKoji Yoshizawa
Koji Yoshizawa
MTMunetoshi Tsukahara
Munetoshi Tsukahara
KKKatsumi Kurihara
Katsumi Kurihara
HNHideo Nagai
Hideo Nagai
Background: Fistula formation has been reported in intraductal papillary-mucinous neoplasms (IPMNs) with or without invasion of the adjacent organs. The presence or absence of invasion is mostly determined by postoperative histological examination rather than by preoperative work-up. Case presentation: A 72 year-old Japanese woman showed remarkable dilatation of the main pancreatic duct (MPD) in the distal region of the pancreas. Subsequent ERCP also showed MPD dilatation, after which the patient suffered moderate pancreatitis. A subsequent gastroscopy revealed a small ulceration that had not been observed in a gastroscopy performed 3 months prior. Mucinous discharge from the ulceration suggested it might be the orifice of a fistula connected to the MPD. En bloc resection including the distal region of the pancreas, spleen, stomach and part of the transverse colon was performed under the pre- and intraoperative diagnosis of an invasive malignant IPMN. However, histopathology revealed the lesion to be of "borderline malignancy" without apparent invasion of the stomach. Light microscopy showed inflammatory cellular infiltrates (mainly neutrophils) around the pancreatogastric fistula, but there was no evidence of neoplastic epithelia lining the fistulous tract. Conclusion: This case highlights that a pancreatogastric fistula can develop after acute inflammation of the pancreas in the absence of cancer invasion. Further information regarding IPMN-associated fistulae is necessary to clarify the pathogenesis, diagnosis, appropriate surgical intervention and prognosis for this disorder.

1 April 2011 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MKMasaru Koizumi
Masaru Koizumi
YHYoshinori Hosoya
Yoshinori Hosoya
KDKatsuya Dezaki
Katsuya Dezaki
TYToshihiko Yada
Toshihiko Yada
HHHiroshi Hosoda
Hiroshi Hosoda
YYYoshikazu Yasuda
Yoshikazu Yasuda

15 August 2004 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
NSNaohiro Sata
Naohiro Sata
MTMunetoshi Tsukahara
Munetoshi Tsukahara
MKMasaru Koizumi
Masaru Koizumi
KYKoji Yoshizawa
Koji Yoshizawa
KKKatsumi Kurihara
Katsumi Kurihara
KSKen Saito
Ken Saito
Background: Small-cell neuroendocrine carcinoma in the duodenum is an extremely rare neoplasm with poor prognosis. Case presentation: A 57-year-old man presented with sudden onset gastrointestinal bleeding and fainting attacks. Duodenoscopy and hypotonic duodenography revealed a 3 × 3 cm protruding tumor with ulcerations situated opposite the ampulla of Vater in the second part of the duodenum. Local excision of the tumor was performed, followed by adjuvant chemotherapy with 5-fluoro uracil and leucovorin. Examination of the tumor by immunohistochemistry and electron microscopy indicated it to be neuroendocrine in nature, expressing synaptophysin and AE1/AE3, and containing dense core granules. The patient showed no sign of recurrence and has been disease-free for more than 48 months after surgery. Conclusions: Most cases of small-cell neuroendocrine carcinoma in the duodenum show rapid progression of the disease, and even radical surgery with or without chemotherapy do not prevent death. We report a rare subtype of small-cell neuroendocrine carcinoma. This subtype appears to have a much better prognosis, and may be amenable to local excision, if the lesion is away from the ampulla of Vater.

8 January 2010
Verified
Journal Article
Closed access
MKMasaru Koizumi
Masaru Koizumi
NSNaohiro Sata
Naohiro Sata
NKNaoya Kasahara
Naoya Kasahara
KMKazue Morishima
Kazue Morishima
HSHideki Sasanuma
Hideki Sasanuma
YYYoshikazu Yasuda
Yoshikazu Yasuda